MRNA.MX

Moderna, Inc.
MexicoMXNEQUITY Healthcare DELAYED
Last price
2,475.00
▲ 213.79 (9.45%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
2,265.00
Prev close
2,261.21
Day high
2,688.69
Day low
2,265.00
Volume
3.75K
Market cap
$988.11B
P/E (TTM)
52W range
414.00 – 2,975.59

Day trading desk

Current session · delayed
Gap from prior close
+0.17%
Prior close 2,261.21
VWAP
2,580.88
-4.10% from price
Relative volume
4.75×
Unusually busy
Session range
18.71%
2,265.00 – 2,688.69
Position in range
50%
Mid range
ATR (14D)
245.67
9.93% of price
Prior day high
2,515.00
PDH
Prior day low
2,185.00
PDL
Bid / ask spread
Quote not published
Session volume
5.08K
Avg 1.07K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+126.04% +127.4%
1M
+146.48% +142.8%
3M
+199.09% +196.0%
6M
+189.07% +178.0%
YTD
+361.86% +349.6%
1Y
+390.70% +370.7%
3Y
+43.70% -30.5%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on MRNA.MX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
29.21M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 6, 26
BANCEL STEPHANE J
Chief Executive Officer
CONVERSION 751.72K $14.40M Direct
Aug 5, 26
BANCEL STEPHANE J
Chief Executive Officer
SELL 499.25K $28.72M Direct
Jul 15, 26
HOGE STEPHEN
President
SELL 53.34K $3.61M Direct
Jul 15, 26
HOGE STEPHEN
President
CONVERSION 53.34K $1.02M Direct
Jul 2, 26
MOCK JAMES M
Chief Financial Officer
1.45K Direct
Jun 15, 26
HOGE STEPHEN
President
SELL 53.34K $2.74M Direct
Jun 15, 26
HOGE STEPHEN
President
CONVERSION 53.34K $1.02M Direct
Jun 5, 26
MOCK JAMES M
Chief Financial Officer
11.80K Direct
Jun 5, 26
KLINGER SHANNON THYME
Officer
CONVERSION 15.27K $107.46K Direct
Jun 4, 26
KLINGER SHANNON THYME
Officer
SELL 3.47K $173.55K Direct
Jun 1, 26
HOGE STEPHEN
President
9.28K Direct
Jun 1, 26
MOCK JAMES M
Chief Financial Officer
2.48K Direct
Jun 1, 26
KLINGER SHANNON THYME
Officer
2.17K Direct
May 28, 26
HOGE STEPHEN
President
2.05K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
AFEYAN NOUBAR BOGHOS
Director Sale
BANCEL STEPHANE J
Chief Executive Officer 22.22M Conversion of Exercise of derivative security
HOGE STEPHEN
President 1.64M Sale
HORNING SANDRA
Director 18.59K Conversion of Exercise of derivative security
HUSSAIN SHAH ABBAS
Director 12.07K Sale
KLINGER SHANNON THYME
Officer 73.56K Conversion of Exercise of derivative security
MOCK JAMES M
Chief Financial Officer 66.44K Conversion of Exercise of derivative security
NABEL ELIZABETH G
Director 19.32K Conversion of Exercise of derivative security
NADER FRANCOIS E.
Director 32.78K Conversion of Exercise of derivative security
SAGAN PAUL L
Director Purchase

Fundamentals

TTM · reported
Market cap$988.11B
Enterprise value$975.28B
Revenue (TTM)$2.23B
Gross profit$-1.47B
EBITDA$-2.20B
Net income$-3.15B
EPS (TTM)$-135.38
Free cash flow$299.25M
Total cash$5.14B
Total debt$1.29B
Book value / share$287.33
Shares outstanding399.24M
Float372.27M
Short % of float
Dividend yield
Beta (5Y)0.90

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book8.61
EV / revenue437.74
EV / EBITDA-444.32
Gross margin-66.02%
Operating margin-557.93%
Profit margin-141.43%
Return on equity-39.00%
Return on assets-13.26%
Debt / equity19.04
Current ratio2.30
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $1.92B$3.20B$6.75B$18.88B -39.9%
Operating revenue $3.30B$4.52B$8.20B$18.43B -26.9%
Cost of revenue $868.00M$1.46B$4.69B$5.42B -40.7%
Gross profit $1.05B$1.74B$2.06B$13.46B -39.3%
Research & development $3.13B$4.54B$4.84B$3.29B -31.1%
Selling, general & admin $1.02B$1.17B$1.55B$1.13B -13.3%
Total operating expense $4.13B$5.68B$6.30B$4.04B -27.3%
Operating income -$3.07B-$3.94B-$4.24B$9.42B +22.1%
Net interest income $304.00M$401.00M$421.00M$200.00M -24.2%
Pre-tax income -$2.77B-$3.61B-$3.94B$9.57B +23.3%
Tax provision $54.00M-$46.00M$772.00M$1.21B +217.4%
Net income -$2.82B-$3.56B-$4.71B$8.36B +20.8%
Net income to common -$2.82B-$3.56B-$4.71B$8.36B +20.8%
Basic EPS -7.26-9.28-12.3321.26 +21.8%
Diluted EPS -7.26-9.28-12.3320.12 +21.8%
EBIT -$2.76B-$3.58B-$4.24B$9.42B +23.0%
EBITDA -$2.54B-$3.39B-$3.62B$9.77B +25.1%
Basic shares 389.00M384.00M382.00M394.00M +1.3%
Diluted shares 389.00M384.00M382.00M416.00M +1.3%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $872.91M -14.1%
Next quarter $689.88M +1.8%
Current year $2.11B +8.4%
Next year $2.46B +16.7%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders7.32%
Held by institutions80.46%
Institutions holding1.09K
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
1,510.65
+63.84% from price
SMA 20
1,238.81
+97.97% from price
SMA 50
1,185.56
+106.86% from price
SMA 100
1,023.35
+141.85% from price
SMA 200
857.36
+186.05% from price
EMA 12
1,628.49
+51.98% from price
EMA 26
1,353.83
+82.81% from price
EMA 50
1,206.99
+105.06% from price
RSI (14)
72.2
Overbought
MACD (12,26,9)
274.66
Hist 174.36
ATR (14)
245.67
10.02% of price
Realised vol 30D
301.4%
Annualised
Bollinger upper
2,363.57
20, 2σ
Bollinger lower
114.06
20, 2σ
50 / 200 cross
Golden
1,185.56 vs 857.36
Trend bias
Above 200
+186.05%

Options chain

Account required
ExpirySpot 2,475.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.95
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
301.4%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-34.6%
Peak to trough
Max drawdown 5Y
-95.5%
Peak to trough
ATR 14
245.67
10.02% of price
Beta (reported)
0.90
5Y monthly, from filing

Rating changes

216 on file
DateFirm ActionFromTo
Aug 21, 26 JP Morgan MAINTAINED Underweight Underweight
Aug 20, 26 Goldman Sachs MAINTAINED Neutral Neutral
Aug 20, 26 UBS MAINTAINED Neutral Neutral
Aug 20, 26 Morgan Stanley MAINTAINED Equal-Weight Equal-Weight
Aug 19, 26 William Blair UPGRADE Market Perform Outperform
Aug 3, 26 Citigroup MAINTAINED Neutral Neutral
Jul 21, 26 Goldman Sachs MAINTAINED Neutral Neutral
Jul 8, 26 Morgan Stanley MAINTAINED Equal-Weight Equal-Weight
Jul 7, 26 RBC Capital MAINTAINED Sector Perform Sector Perform
Jul 7, 26 B of A Securities MAINTAINED Underperform Underperform
Jun 26, 26 Piper Sandler MAINTAINED Overweight Overweight
Jun 8, 26 B of A Securities MAINTAINED Underperform Underperform

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.